Waylis Therapeutics

Risk score

57
Large logo of Waylis Therapeutics

Headquarters

Flag of United States of AmericaUnited States of America

Waylis Therapeutics is based in the state of New Jersey in the United States. The organization produces a range of items including Valium (Diazepam), Eulexin (Flutamide), Humatin (Paromomycin), Leukeran (Chlorambucil), Myleran (Busulfan), and Tabloid (Thioguanine).